This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.


Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.


Sandbox 12005

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
(Your Heading Here (maybe something like 'Structure'))
Current revision (09:36, 19 June 2017) (edit) (undo)
 
Line 14: Line 14:
Tacrine was the first cholinesterase inhibitor approved for the treatment of Alzheimer's disease.
Tacrine was the first cholinesterase inhibitor approved for the treatment of Alzheimer's disease.
-
Tacrine’s ringed structure is stacked between the aromatic rings of Trp84 and Phe330<ref>PMID:8415649</ref>.
+
Tacrine’s ringed structure is stacked between the aromatic rings of <scene name='76/761694/Tacrine/1'>Trp84 and Phe330</scene><ref>PMID:8415649</ref>.
</StructureSection>
</StructureSection>
== References ==
== References ==
<references/>
<references/>

Current revision

Your Heading Here (maybe something like 'Structure')

Acetylcholinesterase with Tacrine bound to it

Drag the structure with the mouse to rotate

References

  1. Harel M, Schalk I, Ehret-Sabatier L, Bouet F, Goeldner M, Hirth C, Axelsen PH, Silman I, Sussman JL. Quaternary ligand binding to aromatic residues in the active-site gorge of acetylcholinesterase. Proc Natl Acad Sci U S A. 1993 Oct 1;90(19):9031-5. PMID:8415649
Personal tools